Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00091936
What this trial is testing

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 592
Large-scale testing (Phase 3)UnknownNCT05305898
What this trial is testing

"MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Military Institute od Medicine National Research Institute 2,000
Large-scale testing (Phase 3)Study completedNCT00158457
What this trial is testing

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 40
Large-scale testing (Phase 3)Study completedNCT02273765
What this trial is testing

Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV-1 InfectionTuberculosis
ANRS, Emerging Infectious Diseases 460
Post-approval studies (Phase 4)UnknownNCT03813771
What this trial is testing

Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification

Who this might be right for
Rheumatoid Arthritis
University of Leeds 106
Testing effectiveness (Phase 2)Temporarily pausedNCT00004999
What this trial is testing

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 350
Testing effectiveness (Phase 2)Study completedNCT00002227
What this trial is testing

Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Dupont Merck 60
Not applicableEnded earlyNCT02323269
What this trial is testing

Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingRelapsing-Remitting Multiple Sclerosis
Biogen 24
Large-scale testing (Phase 3)Ended earlyNCT02409355
What this trial is testing

Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 8
Post-approval studies (Phase 4)Study completedNCT00242216
What this trial is testing

"The Once A Day Protease Inhibitor Regimens"

Who this might be right for
HIV Infections
The University of Texas Health Science Center, Houston 76
Not applicableStudy completedNCT06624020
What this trial is testing

Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia

Who this might be right for
Breast Neoplasms
Pfizer 1,128
Early research (Phase 1)Ended earlyNCT01316185
What this trial is testing

Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)

Who this might be right for
Hepatitis D
Eiger BioPharmaceuticals 3
Testing effectiveness (Phase 2)UnknownNCT06575478
What this trial is testing

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2DiabetesType2diabetes
Beijing Supreme Life Pharmaceutical Technology Co., Ltd. 72
Post-approval studies (Phase 4)UnknownNCT00199121
What this trial is testing

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

Who this might be right for
HIV
Johann Wolfgang Goethe University Hospital
Not applicableStudy completedNCT01285947
What this trial is testing

Comparing the Pain Experience Between Patients Who Have and Who Have Not Undergone Dermatologic Procedures

Who this might be right for
Pain
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT00089466
What this trial is testing

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Looking for participantsNCT07726992
What this trial is testing

SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC

Who this might be right for
Papillary-Only Non-muscle-invasive Bladder Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT01435616
What this trial is testing

A Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 1,538
Testing effectiveness (Phase 2)Study completedNCT00260689
What this trial is testing

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Who this might be right for
ImmunosuppresionThrombocytopeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 136
Not applicableStudy completedNCT05096143
What this trial is testing

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 42,269
Next Page